Clinical Trial Update: A Phase 1 Trial of PfSPZ Vaccine in Healthy Adults to Determine Safety, Tolerability and Efficacy Against Heterologous CHMI [Phase 1]

View source ↗

Summary

Phase 1 trial of PfSPZ Vaccine in healthy adults to evaluate safety, tolerability, and efficacy against heterologous controlled human malaria infection has been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria
• Plasmodium Falciparum Malaria

Drugs mentioned

• PfSPZ Vaccine (Plasmodium falciparum sporozoite vaccine)

Snippet

Sponsor: Sanaria Inc. | Conditions: Malaria, Malaria,Falciparum | Phase 1 | Status: TERMINATED | Results posted: 2024-11-25